Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 56:703-708, 2007
DOI: 10.2337/db06-1545
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kayali, A. G.
Right arrow Articles by Hayek, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kayali, A. G.
Right arrow Articles by Hayek, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Report

Limited Capacity of Human Adult Islets Expanded In Vitro to Redifferentiate Into Insulin-Producing ß-Cells

Ayse G. Kayali1, Luis E. Flores1, Ana D. Lopez1, Burak Kutlu2, Emmanuel Baetge3, Ryuichi Kitamura1, Ergeng Hao1, Gillian M. Beattie1, and Alberto Hayek1

1 Department of Pediatrics, USCD Whittier Institute, University of California at San Diego, La Jolla, California
2 Institute for Systems Biology, Seattle, Washington
3 Novocell, San Diego, California

Address correspondence and reprint requests to Alberto Hayek, Department of Pediatrics, USCD Whittier Institute, 9894 Genesee Ave., Ste. 225, La Jolla, CA 92037-3495. E-mail: ahayek{at}ucsd.edu

Abbreviations: DKK1, Dickkopf 1; HTB, human tumor bladder; NIH, National Institutes of Health; Pdx, pancreatic duodenal homeobox; WHI, Whittier Institute

Limited organ availability is an obstacle to the widespread use of islet transplantation in type 1 diabetic patients. To address this problem, many studies have explored methods for expanding functional human islets in vitro for diabetes cell therapy. We previously showed that islet cells replicate after monolayer formation under the influence of hepatocyte growth factor and selected extracellular matrices. However, under these conditions, senescence and loss of insulin expression occur after >15 doublings. In contrast, other groups have reported that islet cells expanded in monolayers for months progressed through a reversible epithelial-to-mesenchymal transition, and that on removal of serum from the cultures, islet-like structures producing insulin were formed (1). The aim of the current study was to compare the two methods for islet expansion using immunostaining, real-time quantitative PCR, and microarrays at the following time points: on arrival, after monolayer expansion, and after 1 week in serum-free media. At this time, cell aliquots were grafted into nude mice to study in vivo function. The two methods showed similar results in islet cell expansion. Attempts at cell differentiation after expansion by both methods failed to consistently recover a ß-cell phenotype. Redifferentiation of ß-cells after expansion is still a challenge in need of a solution.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.